P. Victor Schut’s Post

  Landmark Bio’s Eli Kraus, Yun Chen,Ph.D., Manish Tandon and Gregg Nyberg, demonstrate application of a rapid analytical method in cutting-edge Extracellular Vesicle (EV)-based therapy biomanufacturing. Based on widely available conventional Flow Cytometer configurations, the method development was presented at the ECI Advancing Manufacture of Cell and Gene Therapies Conference in Coronado, CA. Read about the accuracy, precision, and reliable EV quantitation by Flow Cytometry, its benefit, criticality, and limitation in directly supporting clinical EV biomanufacturing platforms. #ExtracellularVesicles #FlowCytometry  

#Gene and #cell-based therapies have the potential to provide targeted and personalized treatments, according to Charité - Universitätsmedizin Berlin and Bayer. They are a beacon of hope for people for whom conventional therapies have failed or for whom there is no treatment so far. With Charité and Bayer, two partners for major medical progress are coming together who will establish a new center for gene and cell therapy in #Berlin, which is to be established in 2025. More information in first comment #healthforall #teambayer

Thanks American Society of Gene & Cell Therapy for asking me to provide my "quick take" on consent for newly approved gene therapy treatments. Please also watch Samuel H. Hughes, MBA and Jean Johnston provide great guidance on consent for gene therapy trials! #genetherapy #informedconsent #approvedtherapies #patientcare #patientexperience

Check out Dr Kara Poons presentation on "Characterization of gene vectors using TEM" on May 10th at the #ASGCT 2024 conference! #TEM #genetherapy #QuTEM #innovation

Meet with Ion Tcacencu, MD/PhD. and Annemiek Stijnen at this exciting event to discuss how Venn Life Sciences can support you!!!

🔊🔊 this promises to be a really interesting webinar. #iPSC, #communitybuilding, #cellandgenetherapies, Cell and Gene Therapy Catapult

Check out three new, must-watch videos from ASGCT #PatientEducation! In Community Quick Takes: Informed Consent in Gene & Cell Therapy Research, we cover what an individual should know prior to giving their consent, and the role different stakeholders can play to improve this process. #genetherapy #celltherapy https://lnkd.in/e-hyyG5h

Take a look at this article, co-authored by Zhe Liu, PhD, Labcorp staff scientist, which focuses on development of a preclinical anti-AAV antibody assay to enable screening for pre-existing AAV immunity. Discover how this assay can help gene therapy developers identify potential low-responding individuals, increase the likelihood of successful transduction and maximize the utility of the preclinical investigations. Read the full article: http://spr.ly/6040pXp5E #GeneTherapy #AAV #CellandGeneTherapy

In May 2024, the 27th Annual Meeting of American Society of Gene & Cell Therapy (ASGCT) explored the current viral vector-based therapy landscape and the emerging vectors in the field. A panel of experts discuss the trends, conversations, and innovations occurring in the viral vector-based therapy sector at ASGCT.   Read what OrganaBio’s Gabrielle Freitas told The Medicine Maker about what techniques and innovations caused most excitement and which players presented promising data and potential solutions for #CGT: https://lnkd.in/eMm9BzGT #celltherapy #genetherapy #immunotherapy #regenerativemedicine

Don’t forget to attend our sponsored session at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting on Friday, May 10 from 8-8:30 a.m. EDT. This session will cover how strategic collaborations between #CDMOs and #CROs are addressing industry challenges related to #viralvector production, leading to: - Improved AAV production titer with a significant reduction in cost of goods via high-throughput processes and analytical development - Direct scale-up from bench to 2,000L - Strategies for enhancing % full enrichment during downstream processing - Developing customer-centric analytics for viral vector characterization in development and GMP settings Learn more about this sponsored session here: http://spr.ly/6047jdT23